South Korea Pranlukast Market Size & Outlook, 2026-2034


South Korea Pranlukast Market Insights

  • As highlighted in Reed Intelligence analysis, the South Korea Pranlukast Market, worth USD 6.46 Billion in 2025, is forecasted to achieve USD 13.72 Billion by 2034.
  • The South Korea market is anticipated to grow at a CAGR of 8.78% during the period 2026–2034.
  • By 2025, Tablets represented the largest share of the Formulation Type market size.
  • Others is expected to remain the key growth driver within Formulation Type, registering the fastest CAGR during the forecast period.

Other Key Findings


  • South Korea contributed 0.87% to the global Pranlukast Market size in 2025.
  • By 2034, United States is forecasted to remain the largest global market for Pranlukast Market.
  • In Asia Pacific, China is projected to capture the leading share of market size by 2034.
  • Among Asia Pacific markets, Taiwan is expected to post the fastest growth, reaching USD 15.13 Billion by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 6.46 Billion
Market Size In 2034 USD 13.72 Billion
Largest segment Tablets
Units Revenue in USD Billion
CAGR 8.78% (2026-2034)
Segmnetation Covered
Formulation Type
  1. Tablets
  2. Capsules
  3. Oral Suspensions
  4. Others
Application
  1. Asthma Treatment
  2. Allergic Rhinitis Treatment
  3. Bronchitis Management
  4. Others
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Drug Stores
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends